Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "Bill"

1035 News Found

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
interviews | June 22, 2026

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India

Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors


Biopharma funding rebounds in 2026, but capital flows to lower-risk assets
Biopharma | June 22, 2026

Biopharma funding rebounds in 2026, but capital flows to lower-risk assets

M&A activity, IPOs and late-stage investments gain momentum as investors prioritize clinical validation, while early-stage biotech firms continue to face funding challenges


Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition
Drug Approval | June 22, 2026

Aurobindo Pharma USA secures FTC clearance for $250 million Lannett acquisition

Through the transaction, Aurobindo USA will expand its product portfolio in this segment while gaining a U.S.-based manufacturing facility


Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
Healthcare | June 20, 2026

Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3

Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge


Bayer seals $300 million Perfuse deal
News | June 18, 2026

Bayer seals $300 million Perfuse deal

Secures high-stakes glaucoma drug in up to $2.45b bet on eye care pipeline


India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
Policy | June 16, 2026

India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape


Evonik unveils probiotic advance in fight against antibiotic resistance
R&D | June 11, 2026

Evonik unveils probiotic advance in fight against antibiotic resistance

Evonik researchers say they have achieved a significant breakthrough with Ecobiol


Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
News | June 11, 2026

Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies

The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy


NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan
Opinion | June 10, 2026

NCAHP Act has built backbone of India’s healthcare workforce: Nalin Saluja, Co-Founder & CTO, Virohan

The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format